Ionic Liquid- and Polymer-Based Nanostructures for Pharmaceutical and Biomedical Applications

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".

Deadline for manuscript submissions: closed (20 July 2022) | Viewed by 2006

Special Issue Editor


E-Mail Website
Guest Editor
Department of Chemistry, Federal University of Santa Maria, Avenida Roraima, 1000, Camobi, Santa Maria 97105-900, Brazil
Interests: ionic liquid; formulations; antimicrobial compounds and formulations; biomaterials; nanoparticles; surfaces and intermolecular interactions

Special Issue Information

Dear Colleagues,

Developing a nanostructured emulsion-based system for various pharmaceutical and biomedical applications remains a challenge. The use of surfactants in the preparation of nanostructured systems is of paramount importance for stability, as well as for controlling the particle size and driving the assembly system. Ionic Liquids (ILs) with long alkyl chains that are amphiphilic are called surface-active ionic liquids (SAILs). SAILs have physicochemical characteristics that are relevant for phase- and surface-responsive behavior (e.g., critical micelle concentration, oleophobicity, and surface activity). The versatile structures of ILs provide a wide range of possibilities for exploring the hydrophilic–lipophilic balance and intermolecular interactions in nanostructured systems. The incorporation of SAILs into nanostructured systems has already been described, showing that these specific ILs favor system stabilization (colloidal and thermal). Thus, SAIL-based surfactants are a potential alternative to conventional surfactants. In addition to assisting in the formation of nanostructured systems, SAILs can also act in drug delivery systems, since they can be used to increase the solubility of sparingly soluble drugs and to enhance their topical and transdermal delivery. Additionally, depending on the chemical structure, they may be biocompatible and can be used for protection against microorganisms and for enhancing skin penetration. With the aid of SAILs, many pharmaceutical and biomedical products have been developed, and therapeutic effects have improved. This Special Issue aims to identify the current progress in the use of SAILs for preparing nanostructured systems for pharmaceutical and biomedical application, including discussions about fundamental aspects of the structural organization (supramolecular assembly) of ILs and other components (e.g., polymers) of the systems.

Dr. Clarissa P. Frizzo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ionic liquids (ILs)
  • surface-active ionic liquids (SAILs)
  • formulations
  • nanostructured systems
  • drug delivery
  • biomedicine
  • nanomedicine

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

18 pages, 5184 KiB  
Article
Antifungal Activity and Stability of Fluconazole Emulsion Containing Ionic Liquids Explained by Intermolecular Interactions
by Bruno L. Hennemann, Caroline R. Bender, Guilherme S. Moleta, Ânderson R. Carvalho, Luana C. G. Bazana, Alexandre M. Fuentefria and Clarissa P. Frizzo
Pharmaceutics 2022, 14(4), 710; https://0-doi-org.brum.beds.ac.uk/10.3390/pharmaceutics14040710 - 26 Mar 2022
Cited by 1 | Viewed by 1684
Abstract
This research reports accelerated stability experiments, the evaluation of intermolecular interactions, and antifungal assays for fluconazole emulsions prepared using ultrasound (US) and magnetic stirring (MS) in the presence of ionic liquids derived from 1,n-(3-methylimidazolium-1-yl)alkane bromide ([CnMIM]Br; n = 12 [...] Read more.
This research reports accelerated stability experiments, the evaluation of intermolecular interactions, and antifungal assays for fluconazole emulsions prepared using ultrasound (US) and magnetic stirring (MS) in the presence of ionic liquids derived from 1,n-(3-methylimidazolium-1-yl)alkane bromide ([CnMIM]Br; n = 12 or 16). The goals of the investigation are to quantify the stability, identify the forces that drive the formation and stability, and determine the antifungal activity of fluconazole-containing emulsions, and corroborate the data from our previous results that indicated that the emulsion based on [C16MIM]Br seemed to be more stable. In this study, accelerated stability experiments evidenced a considerable stability for the [C16MIM]Br emulsions at two temperatures (25 and 37 °C)—the instability index increased in the following order: US40% < US20% < MS. The 1H NMR data showed that the ILs interacts differently with medium-chain triglycerides (MCT). Two distinct interaction mechanisms were also observed for [C12MIM]Br and [C16MIM]Br with fluconazole, in which the latter formed more compact mixed aggregates than the former. The result was corroborated by diffusion data, which showed that ILs suffered a decrease in diffusion in the presence of fluconazole. The antifungal assay showed that emulsions containing ILs displayed superior activity compared with fluconazole alone. The emulsions also showed potent activity in inhibiting a resistant species (C. glabrata—CG34) to FLZ. All emulsions showed weak irritant potential in HET-CAM assay. Full article
Show Figures

Figure 1

Back to TopTop